ANCA (Antineutrophil Cytoplasmic Antibodies) by Immunofluorescence Assay (IFA) with Dilutions Test in UAE | 750 AED

Executive Summary & Core Metrics

Trusted Clinical Diagnostics – Your ANCA IFA Partnership

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection daily from 8 AM to 11 PM.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The ANCA IFA test is a gold-standard immunofluorescence assay detecting antineutrophil cytoplasmic antibodies (c-ANCA and p-ANCA) with quantitative titers. This method is essential for diagnosing autoimmune vasculitis, including granulomatosis with polyangiitis and microscopic polyangiitis. Performed at our ISO 9001:2015 accredited lab, results are available next day to guide urgent clinical decisions.

Feature	Our Test (DHA-Compliant IFA)	Closest Alternative (ELISA)
Method	Immunofluorescence Assay (IFA) with dilution titers, gold standard	Enzyme-linked immunoassay (ELISA) semi-quantitative
Diagnostic Sensitivity	99.9% (pattern recognition + titer)	85–90% (may miss atypical ANCA)
Turnaround Time	Next-day report (sample by 11 AM)	2–3 days
Regulatory Status	ISO 9001:2015, DHA-licensed	Varies, often non-standardized

Physician Insight & Safety Protocols

"I have relied on IFA-based ANCA testing for over two decades because pattern and titer together provide essential prognostic information in vasculitis. Always interpret results in conjunction with clinical findings and other serologies; a positive ANCA alone is not diagnostic without correlation."

— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132

Medication Advisory

Do not discontinue any prescribed immunosuppressive or corticosteroid therapy without consulting your physician before the test, as abrupt cessation may trigger disease flare.

Safety Exclusion Criteria & Emergency Red Flags

Exclusion Criteria: Active systemic infection or febrile illness may cause false-positive ANCA results; reschedule once infection resolves. Severe haemolysis or lipaemia may interfere with fluorescence interpretation.
Minors: This test for individuals under 18 requires written consent and compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019; home collection for minors only with guardian presence and paediatric approval.
ER Red Flags: If you experience sudden hemoptysis, acute kidney injury (oliguria), severe diffuse alveolar haemorrhage, or rapidly progressive glomerulonephritis, seek emergency care immediately—do not wait for test results.

Important: Clinical decisions should always be guided by a qualified physician under Federal Decree-Law No. 4 of 2016 on Medical Liability.

Patient FAQ & Clinical Guidance

1. What is the ANCA IFA test and why do I need it?

The ANCA by IFA test detects antibodies attacking neutrophils, crucial for diagnosing autoimmune vasculitis like granulomatosis with polyangiitis and microscopic polyangiitis. It distinguishes c-ANCA (PR3) and p-ANCA (MPO) patterns, guiding targeted therapy. Your rheumatologist or nephrologist orders this test when symptoms include unexplained respiratory, renal, or sinus involvement.

2. How is the test performed and how should I prepare?

A simple blood draw collects 2 mL serum after overnight fasting; refrigerated cold-chain transport ensures sample integrity. Our DHA-licensed phlebotomist can perform home collection between 8 AM and 11 PM, with next-day reporting. No other special preparation needed, but inform staff about any medications.

3. What do positive c-ANCA and p-ANCA patterns mean and what's the next step?

A positive c-ANCA suggests granulomatosis with polyangiitis (GPA), while p-ANCA points to microscopic polyangiitis or eosinophilic GPA; false positives occur in infections. Our telephonic clinical guidance will explain your result and recommend further tests like MPO/PR3 ELISA or biopsy, all within DHA protocols.

UAE Regulatory & Data Privacy Adherence

Data Protection & Compliance

All clinical data is processed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and medical liability are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Your results are confidential and encrypted.

Clinical & Logistical Metadata

Test Name	ANCA (Antineutrophil Cytoplasmic Antibodies) by Immunofluorescence Assay (IFA) with Dilutions
Price (AED)	750 AED
Turnaround Time	Next day (sample by 11 AM)
Sample Type / Matrix	Serum (2 mL) – Peripheral venous blood
Methodology Used	Indirect Immunofluorescence Assay (IFA) with quantitative dilution titers
ICD-10-CM Code	M31.3, M31.7
LOINC Code	29619-5
DHA Facility License & Laboratory Address	DHA License: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE